Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lactoferrin for Prevention of Recurrent Bacterial Vaginosis in Pregnancy
NCT05669963Phase 3Unknown
- Sponsor
- Zagazig University
- Start
- Jul 2022
- Primary completion
- Jan 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of lactoferrin in bacterial vaginosis (BV), sponsored by Zagazig University. Status: unknown.
02
Drugs
lactoferrin
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on NCT05669963.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05669963.